Tuesday, November 30, 2021 12:28:46 PM
This should be no surprise to anyone as on June 2, 2021 Sorrento stated that it would seek "....major global partnership(s) to co-develop and co-commercialize Abivertinib."
What should be apparent to all shareholders is that any Big Pharma interested in a global partnership focused on Abivertinib, would also be interested in a global partnership involving Sorrento's entire Cancer, COVID-19, autoimmune and non-opioid pain portfolios.
I look for any partnership(s) to be a signal as to who will eventually buyout Sorrento! Merck, Pfizer, J and J ... every Big Pharma with declining pipelines would love to have the inside track to acquire Sorrento. Look for a multi-Billion upfront payment followed by multi-Billion milestones and double digit royalties and co-development and co-commercialization.
THIS IS A BIG DEAL!
"The refusal of the real is the number one dogma of our time" Rene Girard
Recent SRNE News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM